203 related articles for article (PubMed ID: 21605730)
1. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
3. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
4. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
[TBL] [Abstract][Full Text] [Related]
5. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
Denas G; Cucchini U; Iliceto S; Pengo V
Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
[No Abstract] [Full Text] [Related]
6. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
[TBL] [Abstract][Full Text] [Related]
8. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
10. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.
Crowther MA; Garcia D; Ageno W; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Schulman S; Kovacs M; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
Thromb Haemost; 2010 Jul; 104(1):118-21. PubMed ID: 20458438
[TBL] [Abstract][Full Text] [Related]
11. Practical management of coagulopathy associated with warfarin.
Garcia D; Crowther MA; Ageno W
BMJ; 2010 Apr; 340():c1813. PubMed ID: 20404060
[No Abstract] [Full Text] [Related]
12. Clinical experience with oral versus intravenous vitamin K for warfarin reversal.
Meehan R; Tavares M; Sweeney J
Transfusion; 2013 Mar; 53(3):491-8; quiz 490. PubMed ID: 22738309
[TBL] [Abstract][Full Text] [Related]
13. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
Fan J; Armitstead JA; Adams AG; Davis GA
Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
[TBL] [Abstract][Full Text] [Related]
14. What to do when warfarin therapy goes too far.
Prasad S; Wootten MR; Kulinski N; Chapman SA
J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
[TBL] [Abstract][Full Text] [Related]
15. Elevated international normalized ratio from vitamin K supplement discontinuation.
Miesner AR; Sullivan TS
Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
[TBL] [Abstract][Full Text] [Related]
18. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
[TBL] [Abstract][Full Text] [Related]
20. When bleeding complicates oral anticoagulant therapy. How to anticipate, investigate, and treat.
Brigden ML
Postgrad Med; 1995 Sep; 98(3):153-4, 159-62, 164-5, passim. PubMed ID: 7675740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
